You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股收評:三大指數3連升,恒指重回兩萬四,教育、大金融、醫藥表現活躍

今日,三大指數呈現高開高走行情,恒生指數升2.06%上揚近500點重回兩萬四關口,國企指數、恒生科技指數分別上升1.9%及2.14%,三大指數均錄得3連升。

盤面上, 大型科技股、大金融股、中字頭股等權重普遍上升助力大市上揚,小米升近4%,阿里巴巴、騰訊、京東皆有升幅,尤其是弘業期貨大升超15%表現最為搶眼,中國銀河大升近9%,中國太平、中國平安領升保險股,另外,交通銀行、建設銀行、工商銀行再創新高。

教育股普遍走高,在線教育股升幅居前,權重新東方升8.68%。

生物醫藥股、蘋果概念股、汽車股、航空股、半導體股、濠賭股、餐飲股、重型機械股紛紛上升。

另一方面,伊朗和以色列宣佈停火,前期大升的油氣設備股、港口及海運股、軍工股大幅下跌,山東墨龍大跌超23%,德翔海運大跌超19%,太平洋航運大跌超15%,中遠海能大跌近8%。

具體來看:

在線教育板塊全線收紅,新東方-S升超8%,網龍升超6%,思考樂教育升超5%,卓越教育集團升超3%,東方甄選升超1%。

影視股連續上升,檸萌影視升超28%,阿里影業升超6%,比高集團、稻草熊娛樂升超3%,英皇文化產業升超2%,貓眼娛樂升超1%。

券商股表現活躍,高裕金融升超39%,弘業期貨升超15%,中國銀河、國聯民生升超8%,中泰期貨升超7%,中金公司升超6%,招商證券、申萬宏源、光大證券、中州證券、中信建投升超5%,國泰海通、廣發證券升超4%。

醫美概念股連續6個交易日上升,美麗田園醫療健康升超8%,瑞爾集團升超6%,康哲藥業、鉅子生物、醫思健康升超5%,四環醫藥升超4%,昊海生物科技、三生製藥升超3%,時代天使、復星醫藥升超2%。

醫藥外包概念股走強,藥明康德、昭衍新藥升超4%,康龍化成、藥明生物升超3%,凱萊英、泰格醫藥、金瑞斯生物科技升超2%。

保險股大升,中國太平、中國平安升超5%,中國人民保險集團、陽光保險、新華保險、中國再保險、中國財險、保誠升超4%,中國人壽、友邦保險升超3%,中國太保升超2%。

汽車股上升,零跑汽車升超4%,理想汽車、長城汽車、雅迪控股、比亞迪股份、小鵬汽車、吉利汽車升超3%,華晨中國升超2%,廣汽集團升超1%。

油氣設備與服務板塊全線殺跌,百勤油服跌超32%,山東墨龍跌超23%,中石化油服跌超15%,達力普控股跌超10%,瑞昌國際控股跌超6%,中石化煉化工程、中海油田服務跌超4%。

航運及港口板塊下跌,德翔海運跌超19%,太平洋航運跌超16%,中遠海能跌超9%,中遠海發、中國船舶租賃跌超3%,樂艙物流、青島港跌超2%,招商局港口、海豐國際跌超1%。

黃金股下跌,赤峯黃金、中國白銀集團跌超2%,山東黃金、招金礦業、潼關黃金、珠峯黃金跌超1%。

今日,南向資金淨買入25.89億港元,其中港股通(滬)淨買入8.12億港元,港股通(深)淨買入17.77億港元。

展望未來,天風證券認為,當前板塊輪動的難度正在加大,同時海外地緣衝突擾動、內部流動性收緊的壓力也在上升,建議對港股後續走勢保持謹慎,等待資金面與情緒面出現一定緩解後擇機介入,方向上堅持槓鈴配置,一方面港股銀行板塊仍然存在溢價壓縮空間,另一方面AI產業趨勢驗證期內,繼續關注相關互聯網標的。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account